tiprankstipranks
Trending News
More News >
Ryan Specialty Group (RYAN)
NYSE:RYAN
US Market

Ryan Specialty Group (RYAN) AI Stock Analysis

Compare
63 Followers

Top Page

RY

Ryan Specialty Group

(NYSE:RYAN)

Rating:71Outperform
Price Target:
$76.00
â–²(15.47%Upside)
Ryan Specialty Group's overall stock score is primarily supported by strong financial performance and positive sentiment from the recent earnings call. However, the stock's high valuation and mixed technical indicators limit the attractiveness, while the strategic appointment of a new COO provides additional support.
Positive Factors
Growth Potential
Targeted investments should enable double-digit organic growth over the long term.
Market Position
Ryan's national scale and niche expertise are helping it win market share.
Negative Factors
Interest Rates Impact
Management expects headwinds in 2025 resulting from lower interest rates, impacting fiduciary investment income.
Operational Costs
Lower margins resulted from higher G&A expenses, which were above the estimates, affecting overall performance.

Ryan Specialty Group (RYAN) vs. SPDR S&P 500 ETF (SPY)

Ryan Specialty Group Business Overview & Revenue Model

Company DescriptionRyan Specialty Group Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company was founded in 2010 and is headquartered in Chicago, Illinois.
How the Company Makes MoneyRyan Specialty Group makes money through its two main business segments: wholesale brokerage and underwriting management. In the wholesale brokerage segment, the company acts as an intermediary between insurance carriers and retail brokers, earning brokerage commissions for facilitating the placement of specialty insurance coverages. The underwriting management segment involves managing general underwriter (MGU) operations, where Ryan Specialty Group designs and administers insurance programs on behalf of insurers, earning fees and commissions based on the volume and profitability of the insurance written. Key revenue streams include brokerage commissions, fees from underwriting services, and profit-sharing arrangements with insurance carriers. Strategic partnerships with a wide network of brokers and insurers, along with a strong focus on niche and underserved markets, contribute significantly to its earnings.

Ryan Specialty Group Earnings Call Summary

Earnings Call Date:May 01, 2025
(Q1-2025)
|
% Change Since: 1.73%|
Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment Positive
The call presented a strong overall performance with significant revenue growth driven by organic growth and strategic M&A activities. However, challenges in the property market and a reported GAAP net loss due to tax restructuring present areas of concern. Despite these issues, the company's strategic positioning and robust M&A pipeline suggest a positive outlook.
Q1-2025 Updates
Positive Updates
Strong Revenue Growth
Total revenue grew by 25% to $690 million, driven by organic revenue growth of 12.9% and significant contributions from M&A, adding 13 percentage points.
Adjusted EBITDA and Margin Expansion
Adjusted EBITDA grew 27.5% to $201 million, with the adjusted EBITDA margin expanding 60 basis points to 29.1%.
Successful M&A Activity
The acquisition of USQ Risk added $11 million of incremental annualized revenue. The company has a robust M&A pipeline including small, midsize, and large deals.
Casualty and Transportation Growth
Strong growth in casualty practice, particularly in habitational risks, transportation, construction, and healthcare.
Strategic Positioning and Talent Acquisition
Continued investment in operations and technology, and recruitment of top-flight talent to drive sustainable growth.
Negative Updates
Decline in Fiduciary Investment Income
Revenue growth was partially offset by a decline in fiduciary investment income.
GAAP Net Loss
Reported a GAAP net loss of $4 million due to a non-recurring, non-cash deferred tax expense.
Challenging Property Market
Property pricing declines continued, creating headwinds despite modest growth. The second quarter is expected to present a tough comparison due to prior year conditions.
Increased Leverage
Ended the quarter at 3.8x total net leverage, at the higher end of the comfort corridor, due to the acquisition of velocity and seasonal working capital needs.
Company Guidance
In the first quarter of 2025, Ryan Specialty Holdings reported a robust financial performance with total revenue growth of 25% to $690 million, driven by organic revenue growth of 12.9% and significant contributions from mergers and acquisitions (M&A), which added 13 percentage points. Adjusted EBITDA increased by 27.5% to $201 million, with an expanded adjusted EBITDA margin of 29.1%, up 60 basis points. Adjusted earnings per share grew by 11.4% to $0.39, despite a GAAP net loss of $4 million, impacted by a non-recurring, non-cash deferred tax expense. The company's M&A activities, including the acquisition of USQ Risk, added approximately $11 million in incremental annualized revenue, bolstering its alternative risk offerings. Ryan Specialty remains focused on executing its M&A strategy, maintaining its guidance for 2025, with expectations of 11-13% organic revenue growth and an adjusted EBITDA margin of 32.5-33.5%. The company continues to invest in talent, technology, and platform improvements, positioning itself for sustained growth and profitability.

Ryan Specialty Group Financial Statement Overview

Summary
Ryan Specialty Group demonstrates solid financial health with strong revenue and profit growth, effective cost management, and robust cash generation. However, the high debt-to-equity ratio poses a risk.
Income Statement
85
Very Positive
Ryan Specialty Group has shown consistent revenue growth, with TTM revenue increasing by 5.76% compared to the previous year. The gross profit margin stands strong at 38.36%, and the net profit margin is 2.77%, indicating moderate profitability. The EBIT margin and EBITDA margin are 18.73% and 21.53% respectively, demonstrating effective cost management and operational efficiency.
Balance Sheet
78
Positive
The debt-to-equity ratio is relatively high at 7.13, suggesting a significant reliance on debt financing. However, the return on equity (ROE) is 13.60%, indicating decent returns for shareholders. The equity ratio is 5.48%, reflecting a lower proportion of equity in the asset base, which may pose a risk in economic downturns.
Cash Flow
80
Positive
Free cash flow growth is slightly negative, but the company maintains a healthy operating cash flow to net income ratio of 6.63, indicating strong cash generation relative to earnings. The free cash flow to net income ratio is also favorable at 5.87, supporting the company's ability to fund operations and growth.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
2.66B2.52B2.08B1.73B1.43B1.02B
Gross Profit
1.45B924.63M756.52M596.21M441.15M360.06M
EBIT
449.12M427.81M359.08M181.82M61.56M77.06M
EBITDA
645.58M598.63M497.60M418.32M186.62M235.58M
Net Income Common Stockholders
50.49M94.67M61.04M163.26M65.87M68.10M
Balance SheetCash, Cash Equivalents and Short-Term Investments
203.55M540.20M838.79M992.72M386.96M312.65M
Total Assets
9.89B9.65B7.25B6.38B5.46B4.53B
Total Debt
3.87B3.46B2.16B2.16B1.68B1.69B
Net Debt
3.66B2.92B1.32B1.16B1.30B1.38B
Total Liabilities
8.83B8.55B6.27B5.57B4.86B4.46B
Stockholders Equity
542.52M627.66M559.75M478.40M343.77M69.79M
Cash FlowFree Cash Flow
432.48M467.87M447.43M320.47M263.71M122.89M
Operating Cash Flow
488.58M514.87M477.20M335.51M273.49M135.39M
Investing Cash Flow
-2.32B-1.76B-476.23M-22.42M-457.94M-865.42M
Financing Cash Flow
1.51B1.17B-12.61M314.76M429.28M989.24M

Ryan Specialty Group Technical Analysis

Technical Analysis Sentiment
Negative
Last Price65.82
Price Trends
50DMA
69.08
Negative
100DMA
69.01
Negative
200DMA
68.22
Negative
Market Momentum
MACD
-0.88
Positive
RSI
39.29
Neutral
STOCH
16.37
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RYAN, the sentiment is Negative. The current price of 65.82 is below the 20-day moving average (MA) of 68.92, below the 50-day MA of 69.08, and below the 200-day MA of 68.22, indicating a bearish trend. The MACD of -0.88 indicates Positive momentum. The RSI at 39.29 is Neutral, neither overbought nor oversold. The STOCH value of 16.37 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RYAN.

Ryan Specialty Group Risk Analysis

Ryan Specialty Group disclosed 74 risk factors in its most recent earnings report. Ryan Specialty Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ryan Specialty Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
MTMTG
79
Outperform
$6.38B8.9315.12%1.94%4.64%15.36%
79
Outperform
$5.94B8.5813.29%2.12%9.87%3.41%
AIAIZ
78
Outperform
$10.10B15.4513.20%1.61%6.18%-10.34%
71
Outperform
$17.39B8,894.599.23%0.73%21.56%-21.27%
FAFAF
66
Neutral
$6.15B38.893.23%3.61%0.96%-27.04%
64
Neutral
$12.77B9.717.85%78.06%12.07%-7.97%
FNFNF
64
Neutral
$15.43B13.6614.72%3.62%4.40%33.32%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RYAN
Ryan Specialty Group
65.82
12.85
24.26%
AIZ
Assurant
198.17
32.67
19.74%
FNF
Fidelity National Financial
55.27
7.51
15.72%
FAF
First American Financial
58.93
7.12
13.74%
MTG
MGIC Investment
26.85
6.43
31.49%
ESNT
Essent Group
58.61
4.00
7.32%

Ryan Specialty Group Corporate Events

Shareholder MeetingsBusiness Operations and Strategy
Ryan Specialty Group Approves Key Governance Amendments
Neutral
Jun 4, 2025

On May 30, 2025, Ryan Specialty Holdings, Inc. held its annual meeting where stockholders approved multiple amendments to the company’s Certificate of Incorporation and bylaws. These changes include declassifying the Board of Directors, adopting a majority voting standard for uncontested director elections, and allowing stockholders to call special meetings and take action by written consent. Additionally, the amendments set a sunset date for the voting disparity between Class A and Class B shares and provide for the exculpation of certain officers under Delaware law. These amendments aim to enhance corporate governance and align with market standards, potentially impacting the company’s operational flexibility and shareholder engagement.

The most recent analyst rating on (RYAN) stock is a Hold with a $60.00 price target. To see the full list of analyst forecasts on Ryan Specialty Group stock, see the RYAN Stock Forecast page.

Executive/Board ChangesBusiness Operations and Strategy
Ryan Specialty Group Appoints New Chief Operating Officer
Positive
Mar 27, 2025

On March 27, 2025, Ryan Specialty Holdings, Inc. announced the appointment of Stephen P. Keogh as Chief Operating Officer, effective May 1, 2025. Keogh, with over 32 years of experience at Aon plc, is expected to bring significant operational and leadership expertise to Ryan Specialty. His appointment is seen as a strategic move to enhance the company’s operational excellence and optimize its platform, aligning with its growth ambitions. The compensation package includes a base salary, an annual bonus, and performance stock units contingent on achieving specific growth targets.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.